Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms

NCT04629885 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Vulvovaginal Atrophy

Interventions

DRUG: Oxytocin 400 IU vaginal gel
DRUG: Placebo

Sponsor

PepTonic Medical AB